The International Conference on Juvenile Myoclonic Epilepsy will cut through the confusion that has surrounded Juvenile Myoclonic Epilepsy since its worldwide recognition.

Patients with Juvenile Myoclonic Epilepsy – or Janz Syndrome – still face suboptimal management due to uncertainty about the criteria, treatment in the different age groups, and lifestyle recommendations worldwide recognition of the condition. However, in the past five years many studies in Juvenile Myoclonic Epilepsy patients have provided crucial new insights. Discover what these will mean for the future of JME, at the International Conference on Juvenile Myoclonic Epilepsy at the Bel Air Hotel, The Hague, The Netherlands on October 26th – 28th 2012.
The conference will also cover:
• JME and treatment
• JME and provocative factors
• JME in families
• JME and behavior
• JME and EEG
When you attend, you will gain:
• A better understanding of the multiple genetic factors involved
• More knowledge of the complex clinical phenotype which includes neuropsychological and psychiatric elements
• More knowledge about circadian mechanisms and interaction with the environment
• New concepts about the relationship between JME and other forms of epilepsies
• A better understanding of the long-term evolution
• Insights into new therapeutic strategies
Your questions and case histories can be discussed with the distinguished faculty as well as with the ‘father’ of Juvenile Myoclonic Epilepsy: Prof Dr Dieter Janz from Berlin, Germany.